These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23337235)

  • 1. Transparent interactive decision interrogator-reply to letter to the editor by Michael Coory.
    Bujkiewicz S; Sutton AJ; Abrams KR; Cooper NJ; Spiegelhalter DJ
    Value Health; 2013; 16(1):216-7. PubMed ID: 23337235
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.
    Bujkiewicz S; Jones HE; Lai MC; Cooper NJ; Hawkins N; Squires H; Abrams KR; Spiegelhalter DJ; Sutton AJ
    Value Health; 2011; 14(5):768-76. PubMed ID: 21839417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIDI addresses uncertainty but not indeterminism.
    Coory M
    Value Health; 2013; 16(1):215-6. PubMed ID: 23337234
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997.
    Cooper N; Coyle D; Abrams K; Mugford M; Sutton A
    J Health Serv Res Policy; 2005 Oct; 10(4):245-50. PubMed ID: 16259692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based health technology assessments for the Brazilian National Health System (Sistema Unico de Saúde, SUS) and for all.
    Atallah AN
    Sao Paulo Med J; 2009 May; 127(2):59-60. PubMed ID: 19597678
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based decision making in healthcare in Central Eastern Europe.
    Ferrario A; Baltezarević D; Novakovic T; Parker M; Samardzic J
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):611-5. PubMed ID: 25090222
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of evidence in economic decision models: practical issues and methodological challenges.
    Cooper NJ; Sutton AJ; Ades AE; Paisley S; Jones DR;
    Health Econ; 2007 Dec; 16(12):1277-86. PubMed ID: 18034447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to the letter to the editor 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis' by Louie et al.
    Louie KS; Seigneurin A; Cathcart P; Sasieni P
    Ann Oncol; 2015 May; 26(5):1031-1032. PubMed ID: 25672895
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid review: an emerging approach to evidence synthesis in health technology assessment.
    Khangura S; Polisena J; Clifford TJ; Farrah K; Kamel C
    Int J Technol Assess Health Care; 2014 Jan; 30(1):20-7. PubMed ID: 24451157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting and combining subjective judgments about uncertainty.
    Wolpert RL
    Int J Technol Assess Health Care; 1989; 5(4):537-57. PubMed ID: 2699470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models.
    Haji Ali Afzali H; Karnon J
    Value Health; 2021 Jun; 24(6):755-758. PubMed ID: 34119072
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models.
    Grimm SE; Pouwels X; Ramaekers BLT; Wijnen B; Knies S; Grutters J; Joore MA
    Pharmacoeconomics; 2020 Feb; 38(2):205-216. PubMed ID: 31709496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authors' Reply to Angelis and Kanavos: "Does MCDA Trump CEA?".
    Campillo-Artero C; Puig-Junoy J; Culyer AJ
    Appl Health Econ Health Policy; 2019 Feb; 17(1):125. PubMed ID: 30460622
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Transparency in Decision Models: Current Issues and Potential Solutions.
    Tappenden P; Caro JJ
    Pharmacoeconomics; 2019 Nov; 37(11):1303-1304. PubMed ID: 31642021
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis'.
    Carlsson S; Assel M; Vickers A
    Ann Oncol; 2015 May; 26(5):1031. PubMed ID: 25646367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Framework for Aiding the Translation of Scientific Evidence into Policy: The Experience of a Hospital-Based Technology Assessment Unit.
    Almeida ND; Mines L; Nicolau I; Sinclair A; Forero DF; Brophy JM; Mayo N; Dendukuri N
    Int J Technol Assess Health Care; 2019 Jan; 35(3):204-211. PubMed ID: 31017075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple criteria decision analysis for health technology assessment.
    Thokala P; Duenas A
    Value Health; 2012 Dec; 15(8):1172-81. PubMed ID: 23244821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEVELOPMENT OF THE ONTARIO DECISION FRAMEWORK: A VALUES BASED FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT.
    Krahn M; Miller F; Bayoumi A; Brooker AS; Wagner F; Winsor S; Giacomini M; Goeree R; Schünemann H; van der Velde G; Petersen S; Sikich N; Dhalla I
    Int J Technol Assess Health Care; 2018 Jun; 34(3):290-299. PubMed ID: 29987995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.